Video vs. TTG Respiratory Inhaler Technique Assessment and InstructioN (V-TRaIN)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Asthma and Chronic obstructive pulmonary disease (COPD) results in over a million hospitalizations in the United States annually and COPD is the third leading cause of 30-day re-hospitalizations. Clinical trials have established the efficacy of treatments primarily dispensed via respiratory inhaler devices that reduce morbidity and health care utilization if they are used correctly. Unfortunately, the effectiveness of these medications in real-world settings is limited by the fact that patients often do not use inhalers correctly. Current guidelines recommend assessing and teaching inhaler technique at all health care encounters, including hospitalization. My work has found that over 75% of hospitalized patients in an urban, predominantly underserved population misuse their respiratory inhalers, highlighting a missed opportunity to educate these patients with high potential to benefit. Hospitalization, therefore, provides a potential 'teachable moment' to correct this misuse. My preliminary data indicate that one strategy, in-person teach-to-goal (TTG), is effective in teaching hospitalized patients proper inhaler technique and is more effective than simple verbal instruction.
While TTG is a promising method to improve care for patients who use inhalers, several limitations prevent widespread adoption. First, TTG relies on in-person assessment and education, as well as training and monitoring instructors to ensure fidelity, making it time-consuming and costly. Also, because a single educational session does not ensure long-term retention, post-discharge reinforcement may be needed, which may be impractical with in-person TTG. One potential method to surmount TTG's limitations is use of interactive video module education (VME), a method that has been used for health education in other clinical contexts. Through iterative self-assessments and video-demonstrations on a tablet computer, VME has the potential to be less costly, maintain fidelity, and be more easily extended into the post-discharge setting than in-person TTG. However, certain questions remain about VME. It is unclear whether VME will yield similar results when compared to TTG, or whether patients will have the ability to, and be willing to use, VME in the post-discharge setting. Therefore, before widespread implementation of VME, it is critical to rigorously develop and test VME for inhaler education in the hospital setting. Ultimately, it will also be important to understand patients' ability and willingness to use post-discharge VME for educational reinforcement to allow for this strategy to transition patients across care settings from hospital to home.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 years and older
- Admission to the inpatient medical service and surgical service
- Physician-diagnosed COPD or asthma. We will enroll patients even if the primary reason for admission is not COPD or asthma (e.g., patients admitted for heart failure, but with a physician diagnosis of COPD are eligible).
Exclusion Criteria:
- Currently in an intensive care unit
- Physician declines to provide consent
- Patient unable to provide consent (e.g., history of cognitive impairment, unable to understand English) or declines to provide consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Video Module Education (VME)
The RE will provide participants with a tablet device and will demonstrate how to access VME and complete the pre/post e-learning assessments.
The RE will provide technical support but will neither participate directly in the education nor help with the self-assessments.
The participants will first complete the pre-assessment e-learning tool on the tablet.
They will then watch the video instruction that will provide a complete demonstration with verbal instructions on correct inhaler technique.
Next the participants will complete the post-assessment e-learning tool.
Based on participants' performance, they will be directed to further tailored video-instruction.
The cycle of self-assessment and video instruction will continue until sufficient mastery has been achieved.
|
Participants will complete inhaler education on a tablet device
|
|
Active Comparator: Teach-To-Goal (TTG)
Participants assigned to the TTG condition will be provided with an intensive, iterative education and evaluation strategy that consists of the following steps.
|
Participants will complete intensive in-person inhaler education
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The proportion of participants with metered dose inhaler (MDI) misuse post VME vs. TTG education. This will provide data on the short-term effectiveness of the interventions.
Time Frame: Up to 30 days
|
Assess patient's inhaler technique using Inhaler checklists by the trained assessor.
|
Up to 30 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Symptom burden
Time Frame: Up to 30 days
|
Symptom burden will be assessed using interviewer-administered surveys
|
Up to 30 days
|
|
Quality of Life (QOL)
Time Frame: up to 30 days
|
Use validated disease specific QOL tools (i.e., asthma or COPD QOL tools)
|
up to 30 days
|
|
self-efficacy of inhaler technique
Time Frame: up to 30 days
|
Assess patient's confidence in using their inhalers using a Likert scale response to the question "I am confident that I know how to use this respiratory inhaler correctly."
|
up to 30 days
|
|
Utilization of health care services (outpatient visits, ED and hospital admissions, deaths)
Time Frame: Up to 30 days
|
Up to 30 days
|
|
|
Lung function
Time Frame: Up to 30 days
|
Assess patient's lung function via spirometry
|
Up to 30 days
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 12-1844
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
NCT03745547CompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary Disease
-
NCT05431218CompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease Severe
-
NCT05539547Not yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
NCT06629675RecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway Disease
-
NCT04828837TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With Exacerbation
-
NCT02962999CompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease Mild
-
NCT03573817CompletedChronic Obstructive Pulmonary Disease (COPD)
-
NCT01260389CompletedChronic Obstructive Pulmonary Disease (COPD)
-
NCT04285047UnknownChronic Obstructive Pulmonary Disease (13645005)
-
NCT03644836CompletedBroncho Chronic Obstructive Pulmonary Disease
Clinical Trials on Video Module Education (VME)
-
NCT02278237CompletedChronic Obstructive Pulmonary Disease | Asthma
-
NCT04964570CompletedStigma, Social | Help-Seeking Behavior
-
NCT00899392CompletedInformed Consent | Procedural State Anxiety | Subject's Satisfaction
-
NCT07084077CompletedNarrative Medicine | Empathy | Patient-centredness
-
NCT03910257CompletedChildren Who Registered on the Selected Public Kindergarten and Agree to Follow the Study Assigned by Their Parents and Teacher
-
NCT05237648Completed
-
NCT05677087CompletedHealth Literacy | Dietary Diversity | Infant Feeding Practices
-
NCT01421745CompletedCultural Competence
-
NCT07480798CompletedSupracondylar Humerus Fractures | Nerve Examination
-
NCT03449225UnknownAneuploidy | Autosomal Recessive Disorder